InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（8 笔）
内部人交易记录
首席财务官已披露买入
1
已披露卖出
8
T+90 胜率
100%
T+90 平均收益
+102.7%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the complete record of transactions filed by Bodenstedt Matthias, 首席财务官. Officer active across 1 company, notably MoonLake Immunotherapeutics. Aggregated, 14 reports have been published. Split: 1 buy · 8 sells. Total volume traded: €6.9m. Activity tracked since 19 December 2023. The latest transaction was filed on 11 May 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bodenstedt Matthias
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
39,120 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-071075:0
15,082 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-070259:0
2,794 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-070259:1
13,653 股@ US$20.020.025% mcap50.0% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-055799:0
2,426 股@ US$19.560.0029% mcap0.7% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-044642:0
85,870 股@ US$18.9419.7% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-042629:0
1,925 股@ US$19.510.0023% mcap0.5% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-042629:1
354,296 股0Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-002907:0
294,473 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-124519:0
10,870 股@ US$9.091.2% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-097594:0
标准退出：2026年1月6日 (T+90)
95,763 股0Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-019672:0
94,736 股@ US$59.2291.7% 占其流量Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-23-097671:0
62,972 股Class A ordinary shares, par value $0.0001 per shareSEC:0001013762-23-001300:0
410,796 股Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-23-028294:0
14 条申报中的 14 条
About Bodenstedt Matthias
Matthias Bodenstedt serves as the Chief Financial Officer at MoonLake Immunotherapeutics. In this role, he oversees the company's financial operations, including budgeting and financial reporting. His expertise in finance and management enables him to contribute to the financial strategy and growth of MoonLake. He plays a vital role in managing the company's financial resources.
